[HTML] sciencedirect.com

[HTML][HTML] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of oncology, 2014 - Elsevier
Background S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …
被引用次数：115 相关文章

[引用][C] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of …, 2014 - cir.nii.ac.jp
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC
trial) | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[PDF] semanticscholar.org

[PDF][PDF] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri… - Annals of …, 2014 - pdfs.semanticscholar.org
Background: S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri… - Annals of oncology …, 2014 - pubmed.ncbi.nlm.nih.gov
Background S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …
[HTML] nih.gov

[HTML][HTML] Editor's choice: S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of …, 2014 - ncbi.nlm.nih.gov
Background: S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …

[引用][C] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M YOSHIDA, M ISHIGURO, H MOCHIZUKI… - Annals of …, 2014 - pascal-francis.inist.fr
Author YOSHIDA, M 1; ISHIGURO, M 2; MOCHIZUKI, H 11; KOTAKE, K 12; KAMEOKA, S 13;
TAKAHASHI, K 14; WATANABE, T 15; WATANABE, M 16; BOKU, N 17; TOMITA, N 18; …
[PDF] researchgate.net

[PDF][PDF] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of …, 2014 - researchgate.net
Background: S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …
[HTML] annalsofoncology.org

[HTML][HTML] S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial)

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of …, 2014 - annalsofoncology.org
Background S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of Oncology …, 2014 - europepmc.org
Background S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …

S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).

M Yoshida, M Ishiguro, K Ikejiri, I Mochizuki… - Annals of Oncology …, 2014 - europepmc.org
Background S-1 is an oral fluoropyrimidine whose antitumor effects have been
demonstrated in treating various gastrointestinal cancers, including metastatic colon cancer …